New Evidence Available
Updated Recommendation
A new evidence synthesis was published:2013, Consolidated guidelines on general HIV care and the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach
View latest version (2013)Bibliographic information
GuidelineAntiretroviral therapy of HIV infection in infants and children: towards universal access: recommendations for a public health approach 2010 revision
Year of Publication2010
Issuing InstitutionWHO
Recommendation
Retired
After failure on a first-line regimen of abacavir (ABC) + lamivudine (3TC), zidovudine (AZT) + 3TC is the preferred nucleoside reverse transcriptase inhibitor (NRTI) backbone option for second-line ART; AZT + ddI is an alternative.
Recommended in favor
Strong
Certainty of evidence
Low